Brain Cancer Clinical Trials in Salt Lake City

Showing 41-60 of 149 trials

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

NCT02977780

This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM). The drugs involved in this study are : * Abemaciclib (arm is currently closed to accrual) * Temozolomide (temodar) * Neratinib (arm is currently closed to accrual) * CC115 (arm is currently closed to accrual) * QBS10072S

Glioblastoma

Patrick Wen, MD460 participantsStarted Feb 2017

Birmingham, Alabama, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +9 more locations

COMPLETEDPhase 2< 1 mile

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

NCT01734512

This is an open label study of everolimus in children with recurrent or progressive low-grade glioma.

Pediatric Recurrent Progressive Low-grade GliomasPediatric Progressive Low-grade Gliomas

University of California, San Francisco65 participantsStarted Dec 2012

Los Angeles, California, United States • Los Angeles, California, United States • Oakland, California, United States +15 more locations

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Brain Cancer Trials in Other Cities

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study

Other Conditions in Salt Lake City